REFERENCES
- Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease. More than an aftermath of glomerular injury?. Kidney Int 1999; 56: 1627–1637, [PUBMED], [INFOTRIEVE]
- Price RG. Measurement of N-acetyl B glucosaminidase and its isoenzymes in urine. Methods and clinical applications. Eur J Clin Biochem 1992; 30: 693–705
- Gunder WG, Hofmann W. Marker for the diagnosis and monitoring of renal tubular lesions. Clin Nephrol 1992; 38: 3–7
- Perdichizzi G, Cucinotta D, Fera R, Di Cesare E, Campo S. Correlation between urinary activity of N-acetyl-B-D glucosaminidase and albumin excretion rate in type II diabetic subjects. Acta Diabetol Lat 1987; 24: 149–155, [PUBMED], [INFOTRIEVE]
- Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabet Complications 1998; 12(1)43–60, [CROSSREF]
- Kordonouri O, Hartmann R, Müller C, Danne T, Weber B. Predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes. Horm Res 1998; 50(1)23–27, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kato H, Takashima T, Kishikawa H, Emura S, Ommori K. The significance of urinary N-acetyl B-D-glucosaminidase for predicting early stage diabetic nephropathy. Int J Pract 1997; 51(8)489–490
- Jung K, Pergande M, Schimke E, Ratzmann KP, Ilius A. Urinary enzymes and low molecular mass proteins as indicators of diabetic nephropathy. Clin Chem 1998; 34: 544–547
- Perez-Blanco FJ, Sabatel Hernandez G, Cantero Hinojosa J, Rodriguez-Cuartero A. Urinary N-acetyl beta-glucosaminidase excretion in non-insulin dependent diabetes mellitus: relation with diabetic nephropathy. Clin Nephrol 1998; 49: 132–134, [PUBMED], [INFOTRIEVE]
- Fujita H, Narita T, Morii T, et al. Increased urinary excretion of N-acetylglucosaminidase in subjects with impaired glucose tolerance. Ren Fail 2002; 24: 69–75, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zatz R, Dunn BR, Meyer TW, Brenner B. Prevention of diabetic glomerulopathy by pharmocological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925–1930, [PUBMED], [INFOTRIEVE]
- Gilbert RE, Cox A, Wu LL, et al. Expession of transforming growth factor B1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of angiotensin converting enzyme inhibition. Diabetes 1998; 47: 414–422, [PUBMED], [INFOTRIEVE]
- Ravid M, Brosh D, Levi Z, Bardayan Y, Ravid D, Rachmani R. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus—a randomized, controlled trial. Ann Intern Med 1998; 128: 982–988, [PUBMED], [INFOTRIEVE]
- Mocan Z, Erem C, Yildirim M, Telatar M, Deger O. Urinary beta2 microglobulin and urinary N-acetyl beta-glucosaminidase enzyme activities in early diagnosis of non-insulin dependent diabetes mellitus nephropathy. Diabetes Res 1994; 26: 101–107, [PUBMED], [INFOTRIEVE], [CROSSREF]